Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BioremBIRMF 88 Debt-to-EBITDA is 0.22 as of Jun. 2026, which is 78% below its 10-year median of 0.98. GuruFocus rates BIRMF with a GF Score™ of 88/100 and a GF Value™ of $2.32 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 2,327 Industrial Products companies, Biorem ranks better than 82.72% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Biorem's Debt-to-EBITDA or its related term are showing as below:
BIRMF'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.12 Med: 0.98 Max: 2.45
Current: 0.28
During the past 13 years, the highest Debt-to-EBITDA Ratio of Biorem was 2.45. The lowest was -0.12. And the median was 0.98.
BIRMF's Debt-to-EBITDA is ranked better than 82.72% of 2327
companies
in the Industrial Products industry
Industry Median: 1.71
vs BIRMF: 0.28
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Biorem Debt-to-EBITDA Related Terms
Biorem Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Biorem's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIRMF vs VLTO, ZWS, CECO: Debt-to-EBITDA Comparison
For the Pollution & Treatment Controls subindustry, Biorem's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biorem Debt-to-EBITDA vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Biorem's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Biorem's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Biorem (BIRMF) has a Debt-to-EBITDA of 0.22 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Biorem. This is 78% below median its historical median of 0.98. According to the industry distribution chart, Biorem ranks #402 out of 2327 companies in the Industrial Products industry, placing it in the top 17.3%.
Is Biorem's Debt-to-EBITDA too high?
Biorem's current Debt-to-EBITDA of 0.22 is 78% below median its 10-year median of 0.98. The Industrial Products industry median Debt-to-EBITDA is 1.71. Biorem's value of 0.22 is 87.1% below this industry median. Based on the distribution chart, Biorem ranks #402 out of 2327 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers. Overall, Biorem has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biorem's Debt-to-EBITDA compare to VLTO and ZWS?
According to the Industrial Products industry distribution chart, Biorem ranks #402 out of 2327 companies for Debt-to-EBITDA. This places Biorem in the top 17% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 1.71. Biorem's value of 0.22 is 87.1% below this benchmark. While the company's 10-year median is 0.98 vs. the industry median of 1.71, Biorem has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for an Industrial Products company?
The median Debt-to-EBITDA among Industrial Products companies is 1.71, based on 2,327 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biorem's current Debt-to-EBITDA of 0.22 is 87.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Biorem. For the Industrial Products industry, the median Debt-to-EBITDA is 1.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biorem's current Debt-to-EBITDA is 0.22, which is 78% below median its own 10-year median of 0.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biorem stock overvalued right now?
Based on GuruFocus' analysis, Biorem (BIRMF) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.32, compared to a current price of $2.61 — trading 12.5% above its estimated fair value. The current Debt-to-EBITDA is 0.22, which is 78% below median its 10-year median of 0.98 and 87.1% below the Industrial Products industry median of 1.71. Biorem's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Biorem (BIRMF), the current Debt-to-EBITDA is 0.22 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biorem (BIRMF) Overvalued in 2026?
Based on GuruFocus' analysis, Biorem stock appears to be overvalued.
The current stock price of $2.61 is trading 12.5% above its estimated GF Value™ of $2.32.
GuruFocus considers Biorem to be Modestly Overvalued.
Key valuation signals for BIRMF:
Debt-to-EBITDA: 0.22 (78% below median its 10-year median of 0.98)
GF Value™: $2.32 vs. price of $2.61 (12.5% above fair value)
Industry Position: 87.1% below the Industrial Products median (#402 of 2327)
No single metric tells the full story. See the BIRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
88GF Score
Get the complete analysis for BIRMF
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIRMF has been successfully added to your 
